Form 8-K - Current report:
SEC Accession No. 0001493152-24-028770
Filing Date
2024-07-23
Accepted
2024-07-23 07:00:27
Documents
14
Period of Report
2024-07-19
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47163
  Complete submission text file 0001493152-24-028770.txt   278444

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pwup-20240719.xsd EX-101.SCH 4290
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pwup-20240719_def.xml EX-101.DEF 27913
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pwup-20240719_lab.xml EX-101.LAB 38920
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pwup-20240719_pre.xml EX-101.PRE 26530
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7760
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41293 | Film No.: 241132898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)